Li Runqin, Wu Juan, He Junlin, Wang Yingxiong, Liu Xueqing, Chen Xuemei, Tong Chao, Ding Yubin, Su Yan, Chen Wenqi, Zhang Chen, Gao Rufei
Laboratory of Reproductive Biology, School of Public Health, Chongqing Medical University, Chongqing 400014, P.R. China.
Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Mol Med Rep. 2017 May;15(5):2503-2510. doi: 10.3892/mmr.2017.6322. Epub 2017 Mar 14.
Previous studies have investigated the lower embryo implantation rates in women with polycystic ovary syndrome, obesity and type 2 diabetes, and specifically the association between the abnormal oocyte and embryo and hyperinsulinemia. The importance of hyperinsulinemia on maternal endometrium receptivity remains to be elucidated. The present study used a hyperinsulinemic mouse model to determine whether hyperinsulinemia may affect endometrial receptivity. An insulin intervention mouse model was first established. The serum levels of insulin, progesterone and estradiol were subsequently detected by ELISA assay analysis. The number of implantation sites was recorded using Trypan blue dye and the morphology of mice uteri was investigated using hematoxylin and eosin staining. The expression levels of molecular markers associated with endometrial receptivity were detected by reverse transcription‑quantitative polymerase chain reaction, western blotting and immunohistochemistry analyses. Finally, the importance of mechanistic target of rapamycin (mTOR) expression following insulin treatment was determined. Mice treated with insulin developed insulin resistance and hyperinsulinemia. The number of implantation sites following insulin treatment did not differ between the control and insulin‑treated groups. Additionally, no significant morphological alterations in mice uteri between control and insulin‑treated groups were observed. However, the expression levels of estrogen receptor (Esr) 1, Esr2, progesterone receptor and homeobox A10 associated with endometrial receptivity, were imbalanced during endometrium receptivity when maternal hyperinsulinemia was induced. Western blot analysis revealed that expression levels of endometrial phosphorylated (p)‑mTOR and p‑ribosomal protein S6 kinase β‑1 were significantly greater in the insulin‑treated group. These results demonstrated that although an embryo may implant into endometrium, mice endometrium receptivity in early pregnancy may be impaired by maternal hyperinsulinemia. In addition, mTOR signaling may be involved in this process. The present study provides preliminary results demonstrating that female reproduction may be compromised during hyperinsulinemia, which requires further investigation in future studies.
以往的研究调查了多囊卵巢综合征、肥胖和2型糖尿病女性较低的胚胎着床率,特别是异常卵母细胞和胚胎与高胰岛素血症之间的关联。高胰岛素血症对母体子宫内膜容受性的重要性仍有待阐明。本研究使用高胰岛素血症小鼠模型来确定高胰岛素血症是否会影响子宫内膜容受性。首先建立胰岛素干预小鼠模型。随后通过酶联免疫吸附测定(ELISA)分析检测胰岛素、孕酮和雌二醇的血清水平。使用台盼蓝染料记录着床部位的数量,并使用苏木精和伊红染色研究小鼠子宫的形态。通过逆转录-定量聚合酶链反应、蛋白质免疫印迹和免疫组织化学分析检测与子宫内膜容受性相关的分子标志物的表达水平。最后,确定胰岛素治疗后雷帕霉素靶蛋白(mTOR)表达的重要性。用胰岛素治疗的小鼠出现胰岛素抵抗和高胰岛素血症。胰岛素治疗后的着床部位数量在对照组和胰岛素治疗组之间没有差异。此外,在对照组和胰岛素治疗组之间未观察到小鼠子宫有明显的形态学改变。然而,当诱导母体高胰岛素血症时,与子宫内膜容受性相关的雌激素受体(Esr)1、Esr2、孕酮受体和同源框A10的表达水平在子宫内膜容受性期间失衡。蛋白质免疫印迹分析显示,胰岛素治疗组子宫内膜磷酸化(p)-mTOR和p-核糖体蛋白S6激酶β-1的表达水平显著更高。这些结果表明,尽管胚胎可能植入子宫内膜,但母体高胰岛素血症可能会损害小鼠妊娠早期的子宫内膜容受性。此外,mTOR信号通路可能参与了这一过程。本研究提供的初步结果表明,高胰岛素血症期间女性生殖功能可能会受到损害,这需要在未来的研究中进一步调查。